Ticker Details
NanoViricides Inc. Nanoviricides Inc is a development stage nano-biopharmaceutical company. Its business activities are to discover, develop and commercialize therapeutics to take care of patients suffering from life-threatening viral infections.
IPO Date:	July 5, 2005
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$22M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 4.28%
Avg Daily Range (30 D):	$0.03 | 2.89%
Avg Daily Range (90 D):	$0.06 | 4.07%

Institutional Daily Volume
Avg Daily Volume:	.33M
Avg Daily Volume (30 D):	.28M
Avg Daily Volume (90 D):	.33M

Trade Size
Avg Trade Size (Sh.):	203
Avg Trade Size (Sh.) (30 D):	314
Avg Trade Size (Sh.) (90 D):	294

Institutional Trades
Total Institutional Trades:	30
Avg Institutional Trade:	$1.52M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.71M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	76.29K

News

Dec 12, 2025 @ 6:14 PM 2 Small-Cap Biotechs That Could Reward Patient Inv... Source: Chris Markoch

Jul 11, 2023 @ 12:33 PM Why Better Therapeutics Are Trading Higher By 51%;... Source: Lisa Levin

May 4, 2023 @ 10:45 AM NanoViricides, Inc. to Present at The Inaugural Ef... Source: NanoViricides, Inc.

Feb 28, 2023 @ 1:53 PM uniQure To Rally Around 162%? Here Are 10 Other An... Source: Lisa Levin

Aug 5, 2022 @ 10:12 AM Why NanoViricides Jumped Over 48%; Here Are 106 Bi... Source: Lisa Levin

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.49	$-.11	$-.1
Diluted EPS	$-.49	$-.11	$-.1
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-8.32M	$-2.22M	$-1.79M
Operating Income / Loss	$-8.39M	$-2.23M	$-1.8M
Cost of Revenue
Net Cash Flow	$1.19M	$4.02M	$-.43M
PE Ratio

Splits
Sep 24, 2019	1:20
Sep 10, 2013	2:7